Forget, Patrice
Patullo, Champika
Hill, Duncan
Ambekar, Atul
Baldacchino, Alex
Cata, Juan
Chetty, Sean
Cox, Felicia J.
de Boer, Hans D.
Dinwoodie, Kieran
Dom, Geert
Eccleston, Christopher
Fullen, Brona
Jutila, Liisa
Knaggs, Roger D.
Lavand’homme, Patricia
Levy, Nicholas
Lobo, Dileep N.
Pogatzki-Zahn, Esther
Scherbaum, Norbert
Smith, Blair H.
van Griensven, Joop
Gilbert, Steve
Article History
Received: 14 May 2021
Accepted: 24 February 2022
First Online: 12 March 2022
Declarations
:
: The study was conducted according to the relevant law, guidelines, and aligned with UK Policy Framework for Health and Social Care Research, this study has been granted an exemption from requiring ethics approval (Name of the ethics committee: NHS Research Ethics Committee, REC), according to the Central Office for Research Ethics Committees (COREC) and the National Research Ethics Service (NRES) guidance. Written informed consent was obtained from all participants.
: Not applicable.
: The following authors declare the potential conflict of interest:HDDB is Board Member and Treasurer of the ERAS® Society and president of the Dutch ERAS® Society, member of the global Advisory board of Merck, member of the Scientific Advisory Board of Senzime, member of the global Advisory Board of NMD Pharma, member of the Research Committee and Scientific (SI) Committee of the European Society of Anaesthesiology and Intensive Care.BMF has received an honorarium (speaker and manuscript) for unrelated work from Pfizer-Lily.DNL has received a speaker’s honorarium for unrelated work from Fresenius Kabi in the last 36 months.NS received honoraria for several activities (advisory boards, lectures, manuscripts) by the factories AbbVie, Camurus, Hexal, Janssen-Cilag, MSD, Medice, Mundipharma, Reckitt-Benckiser/Indivior, and Sanofi-Aventis. During the last 3 years he participated in clinical trials financed by the pharmaceutical industry.The other authors did not have any conflict of interest.